Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Frontiers in Genetics|October 17, 2022
The role of lncRNA H19 in tumorigenesis and drug resistance of human CancersXun Zhang, Mingpeng Luo, Jiahang Zhang, et al.
Food Research International (Ottawa, Ont.)|May 12, 2026
Fructooligosaccharides alleviate early-life antibiotic-exposed food allergy via the Indole-3-propionic acid-AhR-Nrf2 Axis: A multi-omics prospective cohort studyLei Wang, Ning Zhu, Fangyuan Cai, et al.
Molecular Oncology|March 19, 2026
Cell-cycle-specific lesion evolution rather than inhibition of double-strand-break repair underpins cisplatin radiosensitizationYe Qiu, Xixi Lin, Emil Mladenov, et al.
Cancer Letters|December 13, 2018
Phosphatidyl inositol 3-kinase (PI3K)-mTOR inhibitor PKI-402 inhibits breast cancer induced osteolysisGuixin Yuan, Zhen Lian, Qian Liu, et al.
Journal of Cellular Physiology|February 7, 2020
Ellagic acid protects ovariectomy-induced bone loss in mice by inhibiting osteoclast differentiation and bone resorptionXixi Lin, Guixin Yuan, Zhaoning Li, et al.
Cancer Communications (London, England)|April 28, 2022
Cancer-associated fibroblasts in breast cancer: Challenges and opportunitiesDengdi Hu, Zhaoqing Li, Bin Zheng, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 5, 2024
Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activityXixi Lin, Guixin Yuan, Bin Yang, et al.
Journal of Cellular Physiology|August 4, 2017
Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathwaysJianwen Cheng, Lin Zhou, Qian Liu, et al.
Frontiers in Pharmacology|October 2, 2019
Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors <i>via</i> a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment ResistanceXixi Lin, Yongliang Jia, Xinwei Dong, et al.
Life Sciences|January 24, 2020
Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorptionKun Tian, Yuangang Su, Jiaxin Ding, et al.
Pageof 7